These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21276771)

  • 21. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNMBP is genetically associated with Alzheimer dementia in the Belgian population.
    Bettens K; Brouwers N; Engelborghs S; De Pooter T; De Deyn PP; Sleegers K; Van Broeckhoven C
    Neurobiol Aging; 2009 Dec; 30(12):2000-9. PubMed ID: 18359537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
    Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
    Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant.
    Piacentini S; Polimanti R; Squitti R; Mariani S; Migliore S; Vernieri F; Rossini PM; Manfellotto D; Fuciarelli M
    Neurosci Lett; 2012 Jan; 506(2):203-7. PubMed ID: 22100662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCDH11X variation is not associated with late-onset Alzheimer disease susceptibility.
    Beecham GW; Naj AC; Gilbert JR; Haines JL; Buxbaum JD; Pericak-Vance MA
    Psychiatr Genet; 2010 Dec; 20(6):321-4. PubMed ID: 20523261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patients.
    Lescai F; Pirazzini C; D'Agostino G; Santoro A; Ghidoni R; Benussi L; Galimberti D; Federica E; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Bagnoli S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Forloni G; Quadri P; Scarpini E; Franceschi C
    J Alzheimers Dis; 2010; 21(2):385-8. PubMed ID: 20555150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association study of susceptibility genes for late-onset Alzheimer's disease in the Japanese population.
    Ohara T; Ninomiya T; Hirakawa Y; Ashikawa K; Monji A; Kiyohara Y; Kanba S; Kubo M
    Psychiatr Genet; 2012 Dec; 22(6):290-3. PubMed ID: 22935915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implication of common and disease specific variants in CLU, CR1, and PICALM.
    Ferrari R; Moreno JH; Minhajuddin AT; O'Bryant SE; Reisch JS; Barber RC; Momeni P
    Neurobiol Aging; 2012 Aug; 33(8):1846.e7-18. PubMed ID: 22402018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease.
    Klimkowicz-Mrowiec A; Marona M; Spisak K; Jagiella J; Wolkow P; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2011; 32(1):26-31. PubMed ID: 21829028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.
    Gaj P; Paziewska A; Bik W; Dąbrowska M; Baranowska-Bik A; Styczynska M; Chodakowska-Żebrowska M; Pfeffer-Baczuk A; Barcikowska M; Baranowska B; Ostrowski J
    J Alzheimers Dis; 2012; 32(1):157-68. PubMed ID: 22785395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons from genome-wide association studies findings in Alzheimer's disease.
    Moraes CF; Lins TC; Carmargos EF; Naves JO; Pereira RW; Nóbrega OT
    Psychogeriatrics; 2012 Mar; 12(1):62-73. PubMed ID: 22416831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.
    Carrasquillo MM; Zou F; Pankratz VS; Wilcox SL; Ma L; Walker LP; Younkin SG; Younkin CS; Younkin LH; Bisceglio GD; Ertekin-Taner N; Crook JE; Dickson DW; Petersen RC; Graff-Radford NR; Younkin SG
    Nat Genet; 2009 Feb; 41(2):192-8. PubMed ID: 19136949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians.
    Piaceri I; Bagnoli S; Lucenteforte E; Mancuso M; Tedde A; Siciliano G; Piacentini S; Bracco L; Sorbi S; Nacmias B
    J Alzheimers Dis; 2011; 24(3):409-13. PubMed ID: 21297266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.
    Medway CW; Abdul-Hay S; Mims T; Ma L; Bisceglio G; Zou F; Pankratz S; Sando SB; Aasly JO; Barcikowska M; Siuda J; Wszolek ZK; Ross OA; Carrasquillo M; Dickson DW; Graff-Radford N; Petersen RC; Ertekin-Taner N; Morgan K; Bu G; Younkin SG
    Mol Neurodegener; 2014 Mar; 9():11. PubMed ID: 24607147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. rs2070424 of the SOD1 gene is associated with risk of Alzheimer's disease.
    Spisak K; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Aleksandra G; Slowik A
    Neurol Neurochir Pol; 2014; 48(5):342-5. PubMed ID: 25440013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of association at single nucleotide polymorphisms in the APOE region.
    Martin ER; Gilbert JR; Lai EH; Riley J; Rogala AR; Slotterbeck BD; Sipe CA; Grubber JM; Warren LL; Conneally PM; Saunders AM; Schmechel DE; Purvis I; Pericak-Vance MA; Roses AD; Vance JM
    Genomics; 2000 Jan; 63(1):7-12. PubMed ID: 10662539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DAPK1 is associated with FTD and not with Alzheimer's disease.
    Tedde A; Piaceri I; Bagnoli S; Lucenteforte E; Piacentini S; Sorbi S; Nacmias B
    J Alzheimers Dis; 2012; 32(1):13-7. PubMed ID: 22785394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.
    Martin ER; Bronson PG; Li YJ; Wall N; Chung RH; Schmechel DE; Small G; Xu PT; Bartlett J; Schnetz-Boutaud N; Haines JL; Gilbert JR; Pericak-Vance MA
    J Med Genet; 2005 Oct; 42(10):787-92. PubMed ID: 16199552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.